 Cell Cycle Proteins
"Cell Cycle Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that control the CELL DIVISION CYCLE. This family of proteins includes a wide variety of classes, including CYCLIN-DEPENDENT KINASES, mitogen-activated kinases, CYCLINS, and PHOSPHOPROTEIN PHOSPHATASES as well as their putative substrates such as chromatin-associated proteins, CYTOSKELETAL PROTEINS, and TRANSCRIPTION FACTORS.
| Descriptor ID |
D018797
|
| MeSH Number(s) |
D12.776.167
|
| Concept/Terms |
Cell Cycle Proteins- Cell Cycle Proteins
- Cell Division Cycle Proteins
- Cell-Cycle Regulatory Proteins
- Cell Cycle Regulatory Proteins
- cdc Proteins
|
Below are MeSH descriptors whose meaning is more general than "Cell Cycle Proteins".
Below are MeSH descriptors whose meaning is more specific than "Cell Cycle Proteins".
This graph shows the total number of publications written about "Cell Cycle Proteins" by people in this website by year, and whether "Cell Cycle Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 8 | 1 | 9 | | 1997 | 9 | 1 | 10 | | 1998 | 7 | 2 | 9 | | 1999 | 10 | 0 | 10 | | 2000 | 4 | 3 | 7 | | 2001 | 6 | 1 | 7 | | 2002 | 7 | 6 | 13 | | 2003 | 7 | 3 | 10 | | 2004 | 6 | 7 | 13 | | 2005 | 9 | 12 | 21 | | 2006 | 12 | 8 | 20 | | 2007 | 10 | 5 | 15 | | 2008 | 10 | 8 | 18 | | 2009 | 7 | 7 | 14 | | 2010 | 6 | 10 | 16 | | 2011 | 9 | 8 | 17 | | 2012 | 10 | 8 | 18 | | 2013 | 5 | 12 | 17 | | 2014 | 14 | 9 | 23 | | 2015 | 5 | 9 | 14 | | 2016 | 11 | 10 | 21 | | 2017 | 7 | 10 | 17 | | 2018 | 7 | 10 | 17 | | 2019 | 6 | 5 | 11 | | 2020 | 4 | 6 | 10 | | 2021 | 6 | 3 | 9 | | 2022 | 2 | 14 | 16 | | 2023 | 6 | 9 | 15 | | 2024 | 1 | 4 | 5 | | 2025 | 4 | 6 | 10 | | 2026 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Cycle Proteins" by people in Profiles.
-
Selvam K, Lu S, Messmer C, Pang Y, Biswas S, Khalil M, Zhang P, Tulaiha R, Zhou MM, Kitamura T, Lauberth SM, Blanco MA, Yang FC, Affar EB, Zhao Z, Zeng L, Wang L, Kutateladze TG. Recruitment of BRD4 to the ASXL1 genomic targets depends on the extra-terminal domain of BRD4. Nat Commun. 2026 Feb 17; 17(1).
-
Zych MG, Contreras M, Mammel AE, Hatch EM. RCC1 depletion drives protein transport defects and rupture in micronuclei. J Cell Biol. 2026 Apr 06; 225(4).
-
Nelson CB, Wells JK, Kesarwani E, Sobinoff AP, Fernando M, Gao J, MacKenzie KL, Poulos RC, Nawaz U, Wang X, Ford HL, Pickett HA. Potent synthetic lethality between PLK1 and EYA family inhibitors in tumors of the central and peripheral nervous systems. Genes Dev. 2026 Feb 02; 40(3-4):267-283.
-
Roberts JE, Huynh PT, Carale LO, Whiteley AM. UBQLN2 is necessary for UBE3A-mediated proteasomal degradation of the domesticated retroelement PEG10. J Cell Sci. 2025 12 15; 138(24).
-
Ananthamohan K, Brady TM, Arif M, Daniels SR, Falkner B, Ferguson M, Flynn JT, Hanevold C, Hooper SR, Ingelfinger JR, Lande M, Martin LJ, Meyers KE, Mitsnefes M, Rosner B, Samuels JA, Kuffel G, Zilliox MJ, Chen QM, Becker RC, Urbina EM, Sadayappan S. A Multiomics Approach to Defining Target-Organ Injury in Youths With Primary Hypertension: The SHIP AHOY Cohort. J Am Heart Assoc. 2025 Nov 04; 14(21):e037649.
-
Matthews AM, Whiteley AM. UBQLN2 in neurodegenerative disease: mechanistic insights and emerging therapeutic potential. Biochem Soc Trans. 2025 Aug 29; 53(4):823-833.
-
Wagner DE, Alsafadi HN, Mitash N, Justet A, Hu Q, Pineda R, Staab-Weijnitz C, Korfei M, Gvazava N, Wannemo K, Onwuka U, Mozurak M, Estrada-Bernal A, Cala-Garcia J, Mutze K, Costa R, Bölükbas D, Stegmayr J, Skronska-Wasek W, Klee S, Ota C, Baarsma HA, Wang J, Sembrat J, Hilgendorff A, Ding J, Günther A, Chambers R, Rosas I, de Langhe S, Kaminski N, Lehmann M, Eickelberg O, Königshoff M. Inhibition of epithelial cell YAP-TEAD/LOX signaling attenuates pulmonary fibrosis in preclinical models. Nat Commun. 2025 Aug 02; 16(1):7099.
-
Martinez A, Stemm-Wolf AJ, Sheridan RM, Taliaferro JM, Pearson CG. The Unkempt RNA-binding protein reveals a local translation program in centriole overduplication. J Cell Biol. 2025 Aug 04; 224(8).
-
Mohan HM, Fernandez MG, Huang C, Lin R, Ryou JH, Seyfried D, Grotewold N, Barget AJ, Whiteley AM, Basrur V, Mosalaganti S, Paulson HL, Sharkey LM. Endogenous retrovirus-like proteins recruit UBQLN2 to stress granules and shape their functional biology. Sci Adv. 2025 Jul 18; 11(29):eadu6354.
-
Becht DC, Biswas S, Xu C, Xuan H, Khalil M, Cai L, Musselman CA, Liu X, Affar EB, Shi X, Wang GG, Kutateladze TG. Multiple transactivation domains of EZH2 bind to the TAZ2 domain of p300 and stimulate the acetyltransferase function of p300. Biochem J. 2025 Jul 02; 482(13):955-968.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|